P2RX7 and cancer: When we evaluated the four intrinsic molecular cancer subtypes, significant increased frequency of P2X7 positivity was observed in luminal B and HER2-enriched BRCA (Figure 1E,F), while no significant changes were detected in luminal A or triple-negative patients (Figure 1G,H).